SRC and triple-negative breast carcinoma: Src has been implicated in mechanisms that underlie the development of hormone therapy resistance in breast cancer (McDonnell and Norris, 2002; Hiscox et al., 2006) and resistance to chemotherapy in triple-negative breast cancer (Wu et al., 2016).